Market Overview
The Pet DNA Testing Market comprises genetic analysis services delivered through saliva, blood, or other sample types to determine breed composition, genetic disease predispositions, and behavioral traits in companion animals. In 2025, the market is valued at approximately $531 million globally, with some industry estimates placing it closer to $590 million for the year. DNA testing has moved beyond research labs into mainstream veterinary clinics, animal shelters, and direct-to-consumer at-home kits, driven by falling sequencing costs and growing consumer interest in personalized pet care.
- •Market valued at ~$531 million in 2025, with competing estimates ranging up to $590 million depending on scope
- •Tested primarily in dogs and cats, with emerging applications for other companion animals
- •Sample types include saliva (most common for at-home kits), blood, and buccal swabs
Growth Drivers
The central driver of market expansion is the global trend of pet humanization, wherein owners increasingly treat pets as family members and invest in health and wellness products accordingly. Rising prevalence of breed-specific genetic disorders has prompted both veterinarians and owners to pursue early screening, while advances in genotyping technology have reduced the cost and turnaround time of tests. Additionally, the integration of DNA-based personalized nutrition and medication plans for pets is creating new use cases beyond simple breed identification.
- •Global pet humanization trend driving willingness to spend on preventive genetic health testing
- •Advancements in affordable, rapid genotyping and sequencing technologies enabling wider adoption
- •Growing use of genetic data to inform personalized nutrition, medication dosing, and breeding decisions
Segmentation and Regional Analysis
The market is segmented by animal type, dogs hold the largest share due to the breadth of breed diversity and corresponding genetic research, while the cat segment is growing rapidly. Segmentation by test type includes breed identification, genetic health screening, and trait analysis, with health-related tests commanding the fastest growth. By sample type, saliva-based tests dominate the consumer segment due to ease of collection, while blood samples are preferred in clinical veterinary settings for comprehensive analysis.
- •Dogs represent the largest animal type segment; cats are the fastest-growing companion animal segment
- •Key test categories: breed identification, genetic disease risk screening, and trait/characteristic profiling
- •North America leads globally, with Europe and Asia-Pacific following as emerging markets
Trends and Outlook
What are the recent trends and outlook?
The market is trending toward integration of pet DNA data into veterinary electronic health records, enabling longitudinal health management based on genetic predispositions. There is also growing consumer demand for multi-pet household profiles and expanded coverage of rare breed genetic markers, particularly as mixed-breed adoption rises globally. Looking ahead, continued consolidation through mergers and acquisitions is expected, alongside partnerships between DNA testing companies and pet insurance providers to offer genetic-risk-adjusted policies.
- •Integration of genetic data into veterinary EHR systems and telemedicine platforms is accelerating
- •Multi-pet and rare-breed genetic marker databases are expanding to serve broader demographics
- •Strategic acquisitions by major animal health and pharmaceutical companies signal long-term market maturation
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.